Filters
Patients with systemic lupus erythematosus (SLE) with low levels of vitamin D tend to have a more severe form of the disease, according to a systematic review and meta-analysis.
A recent study has observed the association of bisphenol A (BPA) and its substitutes with specific metabolic diseases (MDs).
Glycaemic outcomes following sleeve gastrectomy (SG) vary by race and ethnicity, with non-Hispanic Black (NHB) participants showing less favourable outcomes, reports a study.
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have the potential to reduce the frequency of migraines even in patients who do not lose weight—an effect that may be related to a reduction in intracranial pressure, according to a pilot prospective observational study.
Patients without diabetes who use GLP-1 receptor agonists (RAs) display a lower risk of primary open-angle glaucoma (POAG) and ocular hypertension than those who use other weight-loss therapies at 3- and 5-year intervals, a study has shown.
Obesity shows a significant relationship with several indices of asymptomatic cardiac remodelling and vascular atherosclerosis, according to a study. Moreover, this association is mediated by systolic blood pressure (BP).
For adult patients with type 2 diabetes (T2D) who are naïve to insulin, a once-weekly fixed-dose efsitora regimen is noninferior to once-daily glargine at reducing blood glucose levels, according to the phase III treat-to-target QWINT-1 trial.
Two large prospective cohorts show no evidence of an association between the use of oral contraceptives and the risk of liver cancer.
In the treatment of patients with type 2 diabetes, sulfonylureas pose an increased risk of major adverse cardiovascular events (MACE) compared with dipeptidyl peptidase 4 inhibitors (DPP4is), according to a study.
Older adults with type 2 diabetes (T2D) who are using multiple daily insulin injections (MDI) and the Bigfoot Unity System demonstrate durable glycaemic improvement at 6 months, reports a study.
